Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023
   Working Capital/Sales(x) 1.930.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 1.93 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.93
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2025 1.93
144.30
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹67.6 Cr -3.2% -9% -57.9% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,984.7 Cr -2.8% -6.4% -21.9% Stock Analytics
KIRI INDUSTRIES ₹2,894.6 Cr -10% -15.9% -9.6% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,587.0 Cr -6.3% -3.7% -30% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,008.9 Cr -6.6% -14.3% 10.6% Stock Analytics
BODAL CHEMICALS ₹601.4 Cr -4.6% -5.9% -22.3% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-3.2%

-9%

-57.9%

SENSEX

-2%

-2.8%

7.4%


You may also like the below Video Courses